Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study.

Presenter: Leos Pleva

October 24, 2023

Presentation TCT 2023

TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons

Presenter: Matthias Bossard

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

Advertisement

Top Endovascular News of 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study.

TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons

What’s Going to Be Hot at TCT 2023

TCTMD’s Top 10 Most Popular Stories for July 2023

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

Top Endovascular News of 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content